Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections
- PMID: 17918527
- DOI: 10.3171/PED-07/09/213
Treatment of cerebrospinal fluid shunt infections in children using systemic and intraventricular antibiotic therapy in combination with externalization of the ventricular catheter: efficacy in 34 consecutively treated infections
Abstract
Object: There are no randomized studies comparing the efficacy of different antibiotic regimens for the treatment of cerebrospinal fluid (CSF) shunt infections, and in the studies that have been reported, efficacy data are limited. The aim of this study was therefore to report the authors' experience using a specific protocol for the management of shunt infections in children. Standard treatment included a two-stage procedure involving externalization of the ventricular catheter in combination with intraventricular and systemic administration of antibiotic medication followed by shunt replacement. Intraventricular treatment consisted of daily instillations of vancomycin or gentamicin with trough concentrations held at high levels of 7 to 17 mg/L for both antibiotic agents.
Methods: During a 13-year study period, the authors treated 34 consecutive intraventricular shunt infections in 30 children. Infections with coagulase-negative staphylococci predominated, and Gram-negative bacterial infection occurred in five children. Ten of the children were initially treated with intravenous antibiotic therapy for at least 3 days, but this treatment did not sterilize the CSF. After externalization of the ventricular catheter, high-dose intraventricular treatment was given for a median of 8 days (range 3-17 days) before shunt replacement.
Results: The CSF was found to be sterile (cultures were negative for bacteria) in one of three, seven of eight, 20 of 20, and six of six cases after 1, 2, 3, and more than 3 days' treatment, respectively. In no case was any subsequent culture positive after a negative result had been obtained. Clinical symptoms resolved in parallel with the sterilization of the CSF. There were no relapses or deaths during the 6-month follow-up period, and there have been none as of April 2007.
Conclusions: Despite the ventricular catheter being left in place and the short duration of therapy, the treatment regimen described by the authors resulted in quick sterilization of the CSF, a low relapse rate, and survival of all patients in this series.
Similar articles
-
[Antibiotic therapy of infected cerebrospinal fluid in hydrocephalus treated by a shunt].An Esp Pediatr. 1988 Dec;29(6):435-9. An Esp Pediatr. 1988. PMID: 3072889 Review. Spanish.
-
Conservative management of patients with cerebrospinal fluid shunt infections.Neurosurgery. 2006 Apr;58(4):657-65; discussion 657-65. doi: 10.1227/01.NEU.0000204126.54417.46. Neurosurgery. 2006. PMID: 16575329
-
Management of complicated shunt infections: a clinical report.J Neurosurg Pediatr. 2008 Mar;1(3):223-8. doi: 10.3171/PED/2008/1/3/223. J Neurosurg Pediatr. 2008. PMID: 18352767
-
Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days.Pediatr Neurosurg. 2008;44(2):104-11. doi: 10.1159/000113111. Epub 2008 Jan 24. Pediatr Neurosurg. 2008. PMID: 18230923
-
Infections in neurologic surgery. The intraventricular use of antibiotics.Neurosurg Clin N Am. 1992 Apr;3(2):343-54. Neurosurg Clin N Am. 1992. PMID: 1633464 Review.
Cited by
-
Microbiology and treatment of cerebrospinal fluid shunt infections in children.Curr Infect Dis Rep. 2014 Oct;16(10):427. doi: 10.1007/s11908-014-0427-8. Curr Infect Dis Rep. 2014. PMID: 25129115
-
Action of linezolid or vancomycin on biofilms in ventriculoperitoneal shunts in vitro.Antimicrob Agents Chemother. 2012 Jun;56(6):2842-5. doi: 10.1128/AAC.06326-11. Epub 2012 Mar 19. Antimicrob Agents Chemother. 2012. PMID: 22430965 Free PMC article.
-
Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.Clin Microbiol Rev. 2010 Oct;23(4):858-83. doi: 10.1128/CMR.00007-10. Clin Microbiol Rev. 2010. PMID: 20930076 Free PMC article. Review.
-
Cerebrospinal fluid diversion devices and infection. A comprehensive review.Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):889-97. doi: 10.1007/s10096-011-1420-x. Epub 2011 Sep 30. Eur J Clin Microbiol Infect Dis. 2012. PMID: 21960033 Review.
-
Antimicrobial treatment options for neurosurgical ventricular shunt infections in children from 1993 to 2012: a systematic review.Childs Nerv Syst. 2014 May;30(5):841-50. doi: 10.1007/s00381-013-2333-z. Epub 2013 Dec 10. Childs Nerv Syst. 2014. PMID: 24322604
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous